Literature DB >> 21746947

Candida albicans adhesion to and invasion and damage of vaginal epithelial cells: stage-specific inhibition by clotrimazole and bifonazole.

Betty Wächtler1, Duncan Wilson, Bernhard Hube.   

Abstract

Clotrimazole and bifonazole are highly effective antifungal agents against mucosal Candida albicans infections. Here we examined the effects of low levels of clotrimazole and bifonazole on the ability of C. albicans to adhere, invade, and damage vaginal epithelial cells. Although adhesion and invasion were not affected, damage was greatly reduced upon azole treatment. This clearly indicates that low levels of azoles influence specific activities of C. albicans during distinct stages of vaginal epithelium infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21746947      PMCID: PMC3165311          DOI: 10.1128/AAC.00144-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

Review 1.  One-day therapy for vaginal candidiasis. A review.

Authors:  D A Edelman; S Grant
Journal:  J Reprod Med       Date:  1999-06       Impact factor: 0.142

2.  In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric method.

Authors:  M T Blanco; C Pérez-Giraldo; J Blanco; F J Morán; C Hurtado; A C Gómez-García
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

Review 3.  Vaginitis.

Authors:  J D Sobel
Journal:  N Engl J Med       Date:  1997-12-25       Impact factor: 91.245

4.  Isogenic strain construction and gene mapping in Candida albicans.

Authors:  W A Fonzi; M Y Irwin
Journal:  Genetics       Date:  1993-07       Impact factor: 4.562

5.  Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections.

Authors:  F C Odds; C E Webster
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

Review 6.  Immunopathogenesis of recurrent vulvovaginal candidiasis.

Authors:  P L Fidel; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

7.  Efficacy of single- versus multiple-dose clotrimazole therapy in the management of vulvovaginal candidiasis.

Authors:  T Lebherz; E Guess; N Wolfson
Journal:  Am J Obstet Gynecol       Date:  1985-08-01       Impact factor: 8.661

8.  Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.

Authors:  F C Odds; A Cockayne; J Hayward; A B Abbott
Journal:  J Gen Microbiol       Date:  1985-10

9.  Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B.

Authors:  M A Ghannoum; S G Filler; A S Ibrahim; Y Fu; J E Edwards
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

Review 10.  Fungal invasion of normally non-phagocytic host cells.

Authors:  Scott G Filler; Donald C Sheppard
Journal:  PLoS Pathog       Date:  2006-12       Impact factor: 6.823

View more
  13 in total

1.  Clotrimazole dampens vaginal inflammation and neutrophil infiltration in response to Candida albicans infection.

Authors:  Duncan Wilson; Betty Hebecker; David L Moyes; Pedro Miramón; Nadja Jablonowski; Stephanie Wisgott; Stefanie Allert; Julian R Naglik; Bernhard Hube
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

2.  Sulfone derivatives reduce growth, adhesion and aspartic protease SAP2 gene expression.

Authors:  Małgorzata Bondaryk; Zbigniew Ochal; Monika Staniszewska
Journal:  World J Microbiol Biotechnol       Date:  2014-06-01       Impact factor: 3.312

3.  Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans.

Authors:  Kevin Kim; Leeor Zilbermintz; Mikhail Martchenko
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-06-09       Impact factor: 3.944

Review 4.  Attenuation of Candida albicans virulence with focus on disruption of its vacuole functions.

Authors:  Ingar Olsen
Journal:  J Oral Microbiol       Date:  2014-04-01       Impact factor: 5.474

5.  Global analysis of fungal morphology exposes mechanisms of host cell escape.

Authors:  Teresa R O'Meara; Amanda O Veri; Troy Ketela; Bo Jiang; Terry Roemer; Leah E Cowen
Journal:  Nat Commun       Date:  2015-03-31       Impact factor: 14.919

6.  Functional divergence of a global regulatory complex governing fungal filamentation.

Authors:  Elizabeth J Polvi; Amanda O Veri; Zhongle Liu; Saif Hossain; Sabrina Hyde; Sang Hu Kim; Faiza Tebbji; Adnane Sellam; Robert T Todd; Jinglin L Xie; Zhen-Yuan Lin; Cassandra J Wong; Rebecca S Shapiro; Malcolm Whiteway; Nicole Robbins; Anne-Claude Gingras; Anna Selmecki; Leah E Cowen
Journal:  PLoS Genet       Date:  2019-01-07       Impact factor: 5.917

7.  Distribution of Pathogenic Yeasts in Different Clinical Samples: Their Identification, Antifungal Susceptibility Pattern, and Cell Invasion Assays.

Authors:  Satish T Pote; Mahesh S Sonawane; Praveen Rahi; Sunil R Shah; Yogesh S Shouche; Milind S Patole; Madhuri R Thakar; Rohit Sharma
Journal:  Infect Drug Resist       Date:  2020-04-20       Impact factor: 4.003

Review 8.  Vulvovaginal Candidiasis: A Current Understanding and Burning Questions.

Authors:  Hubertine M E Willems; Salman S Ahmed; Junyan Liu; Zhenbo Xu; Brian M Peters
Journal:  J Fungi (Basel)       Date:  2020-02-25

9.  Hsp21 potentiates antifungal drug tolerance in Candida albicans.

Authors:  François L Mayer; Duncan Wilson; Bernhard Hube
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

10.  A tale of two yeasts: Saccharomyces cerevisiae as a therapeutic against candidiasis.

Authors:  Duncan Wilson
Journal:  Virulence       Date:  2016-08-31       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.